Concepedia

Kenneth J. Blackburn

KJ

Statistics

Publications

14

Citations

1.2K

H-Index

13

Active since

1967

Affiliations

Pfizer (United Kingdom)(Current)

Pfizer (United States)

Kenneth J. Blackburn is an author at Pfizer (United Kingdom) specializing in pharmacology, medicine, and pharmacodynamics.

Publications per year

1967–1992

14

Publications

14

Long-acting dihydropyridine calcium antagonists. 1. 2-Alkoxymethyl derivatives incorporating basic substituents

John Arrowsmith, Simon F. Campbell, Peter E. Cross et al. · Journal of Medicinal Chemistry · 1986 · 211 citations

, , +6

UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells.

Michael Gwilt, John Arrowsmith, Kenneth J. Blackburn et al. · Journal of Pharmacology and Experimental Therapeutics · 1990 · 189 citations

, , +17

5-hydroxytryptamine uptake by rat brain

Kenneth J. Blackburn, P.C. French, R. J. Merrills · Life Sciences · 1967 · 149 citations

, , +10

Calcium Channel Blocking Properties of Amlodipine in Vascular Smooth Muscle and Cardiac Muscle In Vitro: Evidence for Voltage Modulation of Vascular Dihydropyridine Receptors

Roger A. Burges, Donald G. Gardiner, Michael Gwilt et al. · Journal of Cardiovascular Pharmacology · 1987 · 128 citations

, , +11

Dofetilide, A Novel Class III Antiarrhythmic Agent

Henrik Rasmussen, Michael J. Allen, Kenneth J. Blackburn et al. · Journal of Cardiovascular Pharmacology · 1992 · 87 citations

, , +17

1–5 of 14